Most Read Articles
5 days ago
Living a sedentary lifestyle may increase the risk of cardiovascular diseases (CVD) even in people with healthy body mass index (BMI), reports a new study.
04 Feb 2019
The carbon-chain length of saturated fatty acids appears to be an important factor in determining its role in cardiovascular health, a recent study has found.
3 days ago
Olanzapine confers a modest therapeutic effect on weight compared with placebo in adult outpatients with anorexia nervosa, a study has shown. However, it does not appear to offer significant benefit for psychological symptoms.
Jairia Dela Cruz, 04 Feb 2019
Treatment with secukinumab results in a higher rate of remission or low-disease activity at week 16 in patients with psoriatic arthritis as compared with placebo, according to a posthoc analysis of the FUTURE 2 study. This effect is sustained at 2 years and is evident in both tumour necrosis factor inhibitor-experienced and -naïve patients.

Underlying heart disease affects preoperative NT-proBNP levels

13 Feb 2018
Early predictors of heart disease are crucial in preventing them.

In patients admitted for cardiac surgery, preoperative levels of N-terminal pro-brain natriuretic peptide (NT-proBNP) are affected by underlying heart diseases which, in turn, affect its predictive value for severe postoperative heart failure (SPHF), a recent study has shown.

Researchers performed a prospective cohort study on 2,978 adults (median age 70 years; 24 percent female) undergoing first-time surgery for coronary artery disease (CAD; n=2,226), mitral regurgitation (MR; n=346) or aortic stenosis (AS; n=406).

Relative to CAD patients (290 ng/L), median levels of preoperative NT-probNP were 1.67 times higher in the AS group (595 ng/L; p<0.0001) and 1.47 times higher in the MR patients (400 ng/L; p<0.0001). The overall median preoperative NT-proBNP concentration was 330 ng/L.

Median levels of preoperative NT-proBNP were significantly higher in participants who eventually developed SPHF (2,060 vs 310 ng/L; p<0.0001). This trend remained significant even in the patient subgroups of CAD (2,345 vs 280 ng/L; p<0.0001), AS (1,290 vs 585 ng/L; p=0.047) and MR (1,650 vs 345 ng/L; p<0.0001).

Preoperative NT-proBNP also had significant discriminatory power for SPHF in patients with CAD (area under the curve [AUC], 0.79; 95 percent CI, 0.73–0.85; p<0.0001) and MR (AUC, 0.80; 0.72–0.87; p<0.0001), but less so for AS (AUC, 0.66; 0.51–0.81; p=0.047). Only in CAD patients was preoperative NT-proBNP an independent risk factor for SPHF (adjusted odds ratio [OR], 2.87; 1.56–5.30; p=0.001).

The predictive value of preoperative NT-proBNP for postoperative mortality was confirmed only in patients with CAD (AUC, 0.78; 0.71–0.85; p<0.0001). The number of cases was too few in the other patient subgroups.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
5 days ago
Living a sedentary lifestyle may increase the risk of cardiovascular diseases (CVD) even in people with healthy body mass index (BMI), reports a new study.
04 Feb 2019
The carbon-chain length of saturated fatty acids appears to be an important factor in determining its role in cardiovascular health, a recent study has found.
3 days ago
Olanzapine confers a modest therapeutic effect on weight compared with placebo in adult outpatients with anorexia nervosa, a study has shown. However, it does not appear to offer significant benefit for psychological symptoms.
Jairia Dela Cruz, 04 Feb 2019
Treatment with secukinumab results in a higher rate of remission or low-disease activity at week 16 in patients with psoriatic arthritis as compared with placebo, according to a posthoc analysis of the FUTURE 2 study. This effect is sustained at 2 years and is evident in both tumour necrosis factor inhibitor-experienced and -naïve patients.